In silico exploration of Lycoris alkaloids as potential inhibitors of SARS-CoV-2 main protease (Mpro)

Coronavirus disease 2019 (COVID-19) is a pandemic whose adverse effects have been felt all over the world. As of August 2022, reports indicated that over 500 million people in the world had been infected and the number of rising deaths from the disease were slightly above 6.4 million. New variants...

Descripció completa

Dades bibliogràfiques

Autors principals:	Fredrick Mutie Musila, Grace W Gitau, Magrate M. Kaigongi, Dickson B. Kinyanyi, Jeremiah M. Mulu, Joseph M. Nguta
Format:	Artigo
Idioma:	Inglês
Publicat:	TMKarpinski Publisher, Tomasz M. Karpiński 2022-09-01
Col·lecció:	European Journal of Biological Research
Matèries:	Lycoris alkaloids SARS-CoV-2 Mpro Molecular docking ADMET screening Molecular dynamic simulations Ligand-receptor interactions
Accés en línia:	http://www.journals.tmkarpinski.com/index.php/ejbr/article/view/593
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!